Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2012

01-10-2012 | Clinical trial

Reducing vasomotor symptoms with acupuncture in breast cancer patients treated with adjuvant tamoxifen: a randomized controlled trial

Authors: Annelie Liljegren, Pia Gunnarsson, Britt-Marie Landgren, Ninna Robéus, Hemming Johansson, Samuel Rotstein

Published in: Breast Cancer Research and Treatment | Issue 3/2012

Login to get access

Abstract

To evaluate true acupuncture to control acupuncture (CTRL) (non-insertive stimulation at non-acupuncture points) in breast cancer patients treated with adjuvant tamoxifen suffering from hot flushes and sweatings. Eighty-four patients were randomized to receive either true acupuncture or CTRL twice a week for 5 weeks. Seventy-four patients were treated according to the protocol. In the true acupuncture group 42% (16/38) reported improvements in hot flushes after 6 weeks compared to 47% (17/36) in the CTRL group (95% CI, −28 to 18%). Both groups reported improvement regarding severity and frequencies in hot flushes and sweatings but no statistical difference was found between the groups. In a subanalysis regarding the severity of sweatings at night a statistically significant difference P = 0.03 was found in the true acupuncture group. Former experience of true acupuncture did not influence the perception of true acupuncture or CTRL. No significant differences in hormonal levels were found before and after treatment. In conclusion, convincing data that true acupuncture is more effective than CTRL in reducing vasomotor symptoms is still lacking. Our study shows that both true and CTRL reduce vasomotor symptoms in breast cancer patients treated with adjuvant tamoxifen.
Literature
1.
go back to reference Fisher B, Constantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371–1388PubMedCrossRef Fisher B, Constantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371–1388PubMedCrossRef
2.
go back to reference Carpenter JS, Andrykowski MA, Cordova M et al (1998) Hot flashes in post menopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. Cancer 82:1682–1691PubMedCrossRef Carpenter JS, Andrykowski MA, Cordova M et al (1998) Hot flashes in post menopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. Cancer 82:1682–1691PubMedCrossRef
3.
go back to reference Ganz PA (2001) Impact of tamoxifen adjuvant therapy on symptoms, functioning, and quality of life. J Natl Cancer Inst Monogr 30:130–134PubMedCrossRef Ganz PA (2001) Impact of tamoxifen adjuvant therapy on symptoms, functioning, and quality of life. J Natl Cancer Inst Monogr 30:130–134PubMedCrossRef
4.
go back to reference Hunter MS, Grunfeld EA, Mittal S et al (2004) Menopausal symptoms in women with breast cancer: prevalence and treatment preferences. Psychooncology 13:769–778PubMedCrossRef Hunter MS, Grunfeld EA, Mittal S et al (2004) Menopausal symptoms in women with breast cancer: prevalence and treatment preferences. Psychooncology 13:769–778PubMedCrossRef
5.
go back to reference Fenlon DR, Corner JL, Haviland J (2009) Menopausal hot flushes after breast cancer. Eur J Cancer Care 18:140–148CrossRef Fenlon DR, Corner JL, Haviland J (2009) Menopausal hot flushes after breast cancer. Eur J Cancer Care 18:140–148CrossRef
6.
go back to reference Holmberg L, Andersson H (2004) HABITS (hormonal replacement therapy after breast cancer—is it safe?), a randomised comparison: trial stopped. Lancet 363:453–455PubMedCrossRef Holmberg L, Andersson H (2004) HABITS (hormonal replacement therapy after breast cancer—is it safe?), a randomised comparison: trial stopped. Lancet 363:453–455PubMedCrossRef
7.
go back to reference White A (2004) A cumulative review of the range and incidence of significant adverse events associated with acupuncture. Acupunct Med 22:122–133PubMedCrossRef White A (2004) A cumulative review of the range and incidence of significant adverse events associated with acupuncture. Acupunct Med 22:122–133PubMedCrossRef
8.
go back to reference Nedstrand E, Wijma K, Wyon Y et al (2005) Vasomotor symptoms decrease in women with breast cancer randomised to treatment with applied relaxation or electro-acupuncture: a preliminary study. Climacteric 8:243–250PubMedCrossRef Nedstrand E, Wijma K, Wyon Y et al (2005) Vasomotor symptoms decrease in women with breast cancer randomised to treatment with applied relaxation or electro-acupuncture: a preliminary study. Climacteric 8:243–250PubMedCrossRef
9.
go back to reference Nedstrand E, Wyon Y, Hammar M et al (2006) Psychological well-being improves in women with breast cancer after treatment with applied relaxation or electro-acupuncture for vasomotor symptom. J Psychosom Obstet Gynaecol 27:193–199PubMedCrossRef Nedstrand E, Wyon Y, Hammar M et al (2006) Psychological well-being improves in women with breast cancer after treatment with applied relaxation or electro-acupuncture for vasomotor symptom. J Psychosom Obstet Gynaecol 27:193–199PubMedCrossRef
10.
go back to reference Frisk J, Carlhäll S, Källström AC et al (2008) Long term follow up of acupuncture and hormone therapy on hot flushes in women with breast cancer: a prospective, randomized, controlled multicentral trial. Climacteric 11:166–174PubMedCrossRef Frisk J, Carlhäll S, Källström AC et al (2008) Long term follow up of acupuncture and hormone therapy on hot flushes in women with breast cancer: a prospective, randomized, controlled multicentral trial. Climacteric 11:166–174PubMedCrossRef
11.
go back to reference Deng G, Vickers A, Yeung S et al (2007) Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients. J Clin Oncol 25:5584–5590PubMedCrossRef Deng G, Vickers A, Yeung S et al (2007) Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients. J Clin Oncol 25:5584–5590PubMedCrossRef
12.
go back to reference Hervik J, Mjåland O (2009) Acupuncture for the treatment of hot flushes in breast cancer patients, a randomized, controlled trial. Breast Cancer Res Treat 116:311–316PubMedCrossRef Hervik J, Mjåland O (2009) Acupuncture for the treatment of hot flushes in breast cancer patients, a randomized, controlled trial. Breast Cancer Res Treat 116:311–316PubMedCrossRef
13.
go back to reference Guthrie JR, Dennerstein L, hopper JL et al (1996) Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women. Obstet Gynecol 88:437–442PubMedCrossRef Guthrie JR, Dennerstein L, hopper JL et al (1996) Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women. Obstet Gynecol 88:437–442PubMedCrossRef
14.
15.
go back to reference Øverlie I, Moen MH, Holte A et al (2002) Androgens and estrogens in relation to hot flushes during the menopausal transition. Maturitas 41:69–77PubMedCrossRef Øverlie I, Moen MH, Holte A et al (2002) Androgens and estrogens in relation to hot flushes during the menopausal transition. Maturitas 41:69–77PubMedCrossRef
16.
go back to reference Dong H, Lüdicke F, Comte I et al (2001) An exploratory pilot study of acupuncture on the quality of life and reproductive hormone secretion in menopausal women. J Altern Complement Med 7:651–658PubMedCrossRef Dong H, Lüdicke F, Comte I et al (2001) An exploratory pilot study of acupuncture on the quality of life and reproductive hormone secretion in menopausal women. J Altern Complement Med 7:651–658PubMedCrossRef
17.
go back to reference Larson B, Collins A, Landgren BM (1997) Urogenital and vasomotor symptoms in relation to menopausal status and the use of hormone replacement therapy (HRT) in healthy women during transition to menopause. Maturitas 28:99–105PubMedCrossRef Larson B, Collins A, Landgren BM (1997) Urogenital and vasomotor symptoms in relation to menopausal status and the use of hormone replacement therapy (HRT) in healthy women during transition to menopause. Maturitas 28:99–105PubMedCrossRef
18.
go back to reference Deadman P, Al-Khafaji M, Baker K (1998) A manual of acupuncture. Journal of Chinese Medicine Publications, Cushing Malloy, Inc., Ann Arbor, MI, USA, pp 103, 158, 189, 218, 348, 477 Deadman P, Al-Khafaji M, Baker K (1998) A manual of acupuncture. Journal of Chinese Medicine Publications, Cushing Malloy, Inc., Ann Arbor, MI, USA, pp 103, 158, 189, 218, 348, 477
19.
go back to reference Streitberger K, Kleinhenz J (1998) Introducing a placebo needle into acupuncture research. Lancet 352:364–365PubMedCrossRef Streitberger K, Kleinhenz J (1998) Introducing a placebo needle into acupuncture research. Lancet 352:364–365PubMedCrossRef
20.
go back to reference Park J, White A, Stevinson C et al (2002) Validating a new non-penetrating sham acupuncture device: two randomised controlled trials. Acupunct Med 20:168–174PubMedCrossRef Park J, White A, Stevinson C et al (2002) Validating a new non-penetrating sham acupuncture device: two randomised controlled trials. Acupunct Med 20:168–174PubMedCrossRef
21.
go back to reference Huang MI, Nir Y, Chen B et al (2006) A randomized controlled pilot study of acupuncture for postmenopausal hot flashes: effect on nocturnal hot flashes and sleep quality. Fertil Steril 86:700–710PubMedCrossRef Huang MI, Nir Y, Chen B et al (2006) A randomized controlled pilot study of acupuncture for postmenopausal hot flashes: effect on nocturnal hot flashes and sleep quality. Fertil Steril 86:700–710PubMedCrossRef
22.
go back to reference Nir Y, Huang MI, Schnyer R et al (2007) Acupuncture for postmenopausal hot flashes. Maturitas 56:383–395PubMedCrossRef Nir Y, Huang MI, Schnyer R et al (2007) Acupuncture for postmenopausal hot flashes. Maturitas 56:383–395PubMedCrossRef
23.
go back to reference Avis NE, Legault C, Coeytaux RR et al (2008) A randomized controlled pilot study of acupuncture treatment for menopausal hot flashes. Menopause 15:1070–1078PubMedCrossRef Avis NE, Legault C, Coeytaux RR et al (2008) A randomized controlled pilot study of acupuncture treatment for menopausal hot flashes. Menopause 15:1070–1078PubMedCrossRef
24.
go back to reference Kim KH, Kang KW, Jung HJ et al (2008) Study protocol: effects of acupuncture on hot flushes in perimenopausal and postmenopausal women—a multicenter randomized clinical trial. Trials 9:70PubMedCrossRef Kim KH, Kang KW, Jung HJ et al (2008) Study protocol: effects of acupuncture on hot flushes in perimenopausal and postmenopausal women—a multicenter randomized clinical trial. Trials 9:70PubMedCrossRef
25.
go back to reference Lee MS, Chin BC, Ernst E (2009) Acupuncture for treating menopausal hot flushes: a systematic review. Climacteric 12:16–25PubMedCrossRef Lee MS, Chin BC, Ernst E (2009) Acupuncture for treating menopausal hot flushes: a systematic review. Climacteric 12:16–25PubMedCrossRef
26.
go back to reference Zaborowska E, Brynhildsen J, Damberg S et al (2007) Effects of acupuncture, applied relaxation, estrogens and placebo on hot flushes in postmenopausal women: an analysis of two prospective, parallel, randomized studies. Climacteric 10:38–45PubMedCrossRef Zaborowska E, Brynhildsen J, Damberg S et al (2007) Effects of acupuncture, applied relaxation, estrogens and placebo on hot flushes in postmenopausal women: an analysis of two prospective, parallel, randomized studies. Climacteric 10:38–45PubMedCrossRef
27.
go back to reference Fenlon DR, Corner JL, Haviland JS (2008) A randomized controlled trial of relaxation training to reduce hot flashes in women with primary breast cancer. J Pain Symptom Manag 35:397–405CrossRef Fenlon DR, Corner JL, Haviland JS (2008) A randomized controlled trial of relaxation training to reduce hot flashes in women with primary breast cancer. J Pain Symptom Manag 35:397–405CrossRef
28.
go back to reference Bland JM, Altman DG (1994) Some examples of regression towards the mean. Br Med J 309(6957):780CrossRef Bland JM, Altman DG (1994) Some examples of regression towards the mean. Br Med J 309(6957):780CrossRef
29.
go back to reference Scheid V (2002) Remodeling the arsenal of Chinese medicine: shared pasts, alternative futures. Ann Am Sociol Assoc (September):136–159 Scheid V (2002) Remodeling the arsenal of Chinese medicine: shared pasts, alternative futures. Ann Am Sociol Assoc (September):136–159
30.
go back to reference Lowe RR, Feyzi JM (1993) Reduction in vasomotor symptoms from tamoxifen over time. J Natl Cancer Inst 85:673–674 Lowe RR, Feyzi JM (1993) Reduction in vasomotor symptoms from tamoxifen over time. J Natl Cancer Inst 85:673–674
31.
go back to reference Loprinzi CL, Zahasky KM, Sloan JA et al (2000) Tamoxifen-induced hot flashes. Clin Breast Cancer 1:52–56PubMedCrossRef Loprinzi CL, Zahasky KM, Sloan JA et al (2000) Tamoxifen-induced hot flashes. Clin Breast Cancer 1:52–56PubMedCrossRef
32.
go back to reference Perez DG, Zahasky KM, Loprinzi CL et al (2007) Tamoxifen-associated hot flashes in women. Support Cancer Ther 4:152–156PubMedCrossRef Perez DG, Zahasky KM, Loprinzi CL et al (2007) Tamoxifen-associated hot flashes in women. Support Cancer Ther 4:152–156PubMedCrossRef
Metadata
Title
Reducing vasomotor symptoms with acupuncture in breast cancer patients treated with adjuvant tamoxifen: a randomized controlled trial
Authors
Annelie Liljegren
Pia Gunnarsson
Britt-Marie Landgren
Ninna Robéus
Hemming Johansson
Samuel Rotstein
Publication date
01-10-2012
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2012
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-010-1283-3

Other articles of this Issue 3/2012

Breast Cancer Research and Treatment 3/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine